Engine Ventures’ Lisa Hansmann and Massachusetts Institute of Technology's Brian Deese propose a bold national framework that harnesses AI’s growing energy demand to accelerate the scaling of clean energy. As demand for AI proliferates, its energy consumption is crashing headlong into existing energy infrastructure. An AI additionality requirement for new clean energy capacity to meet new computing demand, paired with a fast-tracked approval process for those clean energy projects, ensures the expansion of AI and clean energy go hand in hand. Read Hansmann and Deese’s article in Heatmap News outlining how a national framework can ensure that we scale innovation in AI and clean energy in tandem to build U.S. strength in the sectors critical to winning the 21st century. https://lnkd.in/eXm6tcux
Engine Ventures
风险投资与私募股权管理人
Cambridge,MA 19,477 位关注者
A venture firm that invests in early stage Tough Tech founders solving our most critical global challenges.
关于我们
A venture firm that invests in early stage Tough Tech founders solving our most critical global challenges.
- 网站
-
https://engineventures.com
Engine Ventures的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 11-50 人
- 总部
- Cambridge,MA
- 类型
- 合营企业
- 创立
- 2017
地点
-
主要
750 Main Street
US,MA,Cambridge,02139
Engine Ventures员工
动态
-
This week, Silicon Valley Bank and Congruent Ventures released their 50 by 2050: Pioneers in Carbon Reduction list. The list - including Commonwealth Fusion Systems, Form Energy, VEIR, Boston Metal, and AtmosZero - features climate tech companies creating carbon reduction solutions to enable a net zero future. Congratulations.
Thrilled to unveil the new 50 by 2050 list we co-authored with Congruent Ventures. The list highlights the climate tech companies that are pioneering the carbon reduction solutions that will enable a net zero future. While climate change is daunting, we are encouraged by the entrepreneurial energy that is rising to meet the challenge. Read the full report: https://lnkd.in/gAtbcZpt #climatetech #innovation
-
Today marks an incredible milestone for the Cellino team. Cellino has been awarded $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). The first project to be funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement, this capital will drive the development of Cellino’s ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Congratulations to the team!
?? Today marks an extraordinary milestone at Cellino! We are thrilled to announce that our team has been awarded up to $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). This funding will drive the development of our ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement. With ARPA-H’s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized induced pluripotent stem cells at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. We are excited to move closer to making “Your Cells, Your Cure?” a reality for millions of patients. We are thrilled about this opportunity to advance our goal of making patient-specific stem cell-derived therapies available for broad patient audiences. ?? Read the full release: https://bwnews.pr/4gfrjlb #ARPAH #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenerativeMedicine #BiotechBreakthroughs #CellinoBio #YourCellsYourCure #Biomanufacturing
Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)
businesswire.com
-
Congratulations Mantel on the $30 million Series A! With backing from leaders in the energy industry, the company is scaling its molten borate carbon capture technology, which could cut costs by more than 50%. Spun out of Massachusetts Institute of Technology’s Department of Chemical Engineering, Mantel is reinventing carbon capture with a new material: molten salts designed to operate best at the high temperatures found inside boilers, kilns, and furnaces. Mantel’s approach recaptures high-quality heat, dramatically reducing the net energy needed for the absorption of CO2 from exhaust and its subsequent desorption to pure CO2. This new funding will be used to launch a demonstration project at an industrial site, setting the stage for the full-scale commercial deployment of Mantel’s high-temperature carbon capture systems. https://lnkd.in/e3H_aQGy
Climate tech startup?Mantel to use molten salt to capture factory flue CO2 with $30 million funding from Shell, VCs
reuters.com
-
One of my favorite things is to have a conversation with builders & founders about the personal experience and complexity of working to bring new deep tech to the point where it makes a real difference in our world. So looking forward to this!
?? We’re honored for our CEO & Co-Founder, Nabiha Saklayen to speak at #EmTech MIT Technology Review, happening from Sept. 30 - Oct. 1! Nabiha will join Reed Sturtevant, General Partner at Engine Ventures, in the session "Lessons Learned from Tough Tech" at 3:45 PM EDT on Day 1 (Sept. 30). They will explore how transformative “tough tech” can solve the world’s most pressing challenges by merging breakthrough #science, #engineering, and #leadership. Topics covered will include the ideation process that brings long-term tough tech projects to market in the most economical and efficient way possible. ?? Register to join us at MIT Campus?in #Cambridge, MA, or online at https://bit.ly/3Tfzy6T Massachusetts Institute of Technology #RegenerativeMedicines #DeepTech #Biotech #Innovation #Biomanufacturing #AI #MachineLearning #PersonalizedMedicine #YourCellsYourCure #CellinoBio
-
As batteries are increasingly adapted and deployed on a massive scale for electric vehicle fleets, the demand for lithium is expected to grow exponentially. Lilac Solutions is commercializing an Ion Exchange (IX) Direct Lithium Extraction Technology for brine resources that is significantly faster, cheaper, and more scalable than existing technologies. Bloomberg spoke with Lilac CEO Raef Sully who discusses the importance of investing in directly lithium companies now: https://lnkd.in/gHRQA4nC
Lithium Startups Bet on High Demand in Battery-Powered Future
bloomberg.com
-
“Military might, geopolitical influence, and economic dominance all largely depend on technological superiority. Without strong research universities and the scientific and technological advances they discover and invent, the United States could not possibly keep up with China.” Massachusetts Institute of Technology president emeritus L. Rafael Reif emphasizes the importance of investing in both curiosity-driven research and the commercialization of innovative ideas to ensure that the U.S. remains a global leader. Reif points to The Engine Ventures as an example of what our country needs more of: an organization providing capital, operational expertise, and a powerful academic, commercial, and governmental network to build and scale companies unlocking massive opportunities in climate change, human health, and advanced systems. https://lnkd.in/enMyAaum
Strong universities make for a strong United States - The Boston Globe
bostonglobe.com
-
Are you a climate tech founder looking to understand your options for funding beyond traditional venture capital? As the landscape of climate tech investment continues to evolve, understanding the financing options available to you is crucial. Join our upcoming webinar, "The Climate Tech Capital Stack," on August 15 at 2:30 PM EST, to learn about the emerging climate tech capital stack and how to navigate the new fundraising landscape. You’ll hear from experts in climate tech financing, including: ?? Lisa Hansmann – Principal, Engine Ventures ?? Campbell Howe – Senior Advisor, DOE Loan Programs Office ?? Gabriel Scheer – Senior Director of Innovation, Elemental Excelerator The panel will be moderated by Alex Prather, Newlab’s Director of Ventures. Register Now → https://buff.ly/4d48r6B
-
Today, DBOS, Inc. welcomed Jeremy Edberg as its new CEO. Jeremy brings decades of experience in cloud product, engineering, and growth leadership to the team. Learn more about Jeremy’s career and his plans for DBOS here: https://lnkd.in/eTUFTqS4
-
Congratulations Kano Therapeutics for their $7.15 million seed round! Spun out of an MIT lab, Kano is successfully harnessing single-stranded DNA as a safe, efficient, and flexible biomaterial for gene insertions.
In 2021, during the Nucleate Activator program, I first discovered Endpoints News — proof of how new I was to biopharma! Now, after being a subscriber for three years, I have the opportunity to share this article with you, written by the phenomenal Ryan Cross. https://lnkd.in/ePnx9TfD I need thank my co-founders John Vroom, Mark Bathe and some special organizations that have guided me from coming to the US in 2020 to leading an organization with the most fantastic scientists and developing therapeutic opportunities for gene insertions at Kano Therapeutics. Massachusetts Institute of Technology, UMass Boston, Activate, The Termeer Foundation, The Engine, Engine Ventures, Vsquared Ventures, Amino Collective, Metaplanet, Taihill Venture
Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion
endpts.com